Risk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia

2013289 citationsJournal Article

Authors

Yuichiro Shindo · Nagoya University Hospital

Ryota Ito · Japanese Red Cross Nagoya Daiichi Hospital

Daisuke Kobayashi · Tosei General Hospital

Masahiko Ando

Motoshi Ichikawa · Gifu Prefectural Tajimi Hospital

Akira Shiraki · Ogaki Municipal Hospital

Yasuhiro Gotô · Nagoya Ekisaikai Hospital

Abstract

The clinical profile of HCAP was different from that of CAP. However, physicians can predict drug resistance in patients with either CAP or HCAP by taking account of the cumulative number of the risk factors. Clinical trial registered with https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000004001&language=E ; number UMIN000003306.

Topics & Keywords

Pneumonia and Respiratory Infections Pneumocystis jirovecii pneumonia detection and treatment Nosocomial Infections in ICU

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Respiratory and Critical Care Medicine

Volume 188, Issue 8, pp. 985-995

DOI: 10.1164/rccm.201301-0079oc

Field-Weighted Citation Impact: 17.50